Waters Corp

1WAT

Company Profile

  • Business description

    Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

  • Contact

    34 Maple Street
    MilfordMA01757
    USA

    T: +1 508 478-2000

    E: [email protected]

    https://www.waters.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    7,600

Stocks News & Analysis

stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.
stocks

ASX share ticks all the popular thematic boxes

The shares are overvalued as investors are overly excited about defence and gold exposure.
stocks

Bluescope offer knocked back by board

Our view on the potential for additional offers.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,138.5011.400.12%
CAC 408,358.763.33-0.04%
DAX 4025,405.34143.700.57%
Dow JONES (US)49,590.2086.130.17%
FTSE 10010,140.7016.100.16%
HKSE26,852.68244.200.92%
NASDAQ23,733.9062.560.26%
Nikkei 22553,576.041,636.153.15%
NZX 50 Index13,656.0527.24-0.20%
S&P 5006,977.2710.990.16%
S&P/ASX 2008,808.5017.200.20%
SSE Composite Index4,155.939.36-0.22%

Market Movers